These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 39171280)
1. Risk of extended viral shedding of Omicron BA.2 in Shanghai: Implications for vaccination strategy optimization. Huang J; Huang L; Xi J; Li Y; Zhou J; Bao Z; Cheng Q; Li Q; Zhou M; Zhao R; Li Y Chin Med J Pulm Crit Care Med; 2023 Dec; 1(4):241-248. PubMed ID: 39171280 [TBL] [Abstract][Full Text] [Related]
2. Factors associated with prolonged viral shedding of SARS-CoV-2 Omicron variant infection in Shanghai: A multicenter, retrospective, observational study. Liu W; Gong F; Zheng X; Pei L; Wang X; Yang S; Zhao S; Yang Z; Lin J; Jing F; Shang H; Bi Y; Wei D; Chen E; Chen Y J Med Virol; 2023 Dec; 95(12):e29342. PubMed ID: 38130170 [TBL] [Abstract][Full Text] [Related]
3. Comorbidities prolonged viral shedding of patients infected with SARS-CoV-2 omicron variant in Shanghai: A multi-center, retrospective, observational study. Pei L; Chen Y; Zheng X; Gong F; Liu W; Lin J; Zheng R; Yang Z; Bi Y; Chen E J Infect Public Health; 2023 Feb; 16(2):182-189. PubMed ID: 36566602 [TBL] [Abstract][Full Text] [Related]
4. Viral load dynamics in asymptomatic and symptomatic patients during Omicron BA.2 outbreak in Shanghai, China, 2022: A longitudinal cohort study. Ai J; Zhou J; Li Y; Sun F; Ge S; Zhang H; Wu Y; Wang Y; Zhang Y; Wang H; Cai J; Zhou X; Wang S; Li R; Feng Z; Xu X; Yan X; Zhao Y; Zhang J; Yu H; Zhang W Virol Sin; 2024 Oct; ():. PubMed ID: 39396663 [TBL] [Abstract][Full Text] [Related]
5. Inactivated COVID-19 vaccine booster dose shortened the viral shedding time of patients infected with the Omicron variant BA.2. Wu J; Shi X; Tao B; Zhan Y; Lu X; Wang J Int J Infect Dis; 2023 Jun; 131():26-31. PubMed ID: 36948448 [TBL] [Abstract][Full Text] [Related]
6. A Nomogram for Predicting Delayed Viral Shedding in Non-Severe SARS-CoV-2 Omicron Infection. Yu T; Dong J; Qi Q; Lv Q; Li J; Huang C; Cai X Infect Drug Resist; 2023; 16():2487-2500. PubMed ID: 37138833 [TBL] [Abstract][Full Text] [Related]
7. Molnupiravir, Nirmatrelvir/Ritonavir, or Sotrovimab for High-Risk COVID-19 Patients Infected by the Omicron Variant: Hospitalization, Mortality, and Time until Negative Swab Test in Real Life. Cegolon L; Pol R; Simonetti O; Larese Filon F; Luzzati R Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242504 [No Abstract] [Full Text] [Related]
8. Development and validation of a nomogram to predict failure of 14-day negative nucleic acid conversion in adults with non-severe COVID-19 during the Omicron surge: a retrospective multicenter study. Gui H; Zhang Z; Chen B; Chen Y; Wang Y; Long Z; Zhu C; Wang Y; Cao Z; Xie Q Infect Dis Poverty; 2023 Feb; 12(1):7. PubMed ID: 36750862 [TBL] [Abstract][Full Text] [Related]
9. Dynamics of disease characteristics and viral RNA decay in patients with asymptomatic and mild infections during the Omicron wave in Shanghai, China: A retrospective cohort study. Kang W; Yang P; Dang B; Zhang W; Gang Y; Wang W; Ma C; Zhao Y; Zhang Y; Hao C; Quan H; Li J; Cao J; Kang W; Shang L Int J Infect Dis; 2023 May; 130():60-70. PubMed ID: 36849069 [TBL] [Abstract][Full Text] [Related]
10. Transmission characteristics and inactivated vaccine effectiveness against transmission of the SARS-CoV-2 Omicron BA.2 variant in Shenzhen, China. He X; Liao Y; Liang Y; Yu J; Gao W; Wan J; Liao Y; Su J; Zou X; Tang S Front Immunol; 2023; 14():1290279. PubMed ID: 38259438 [TBL] [Abstract][Full Text] [Related]
11. Preliminary Study of the Protectiveness of Vaccination Against the COVID-19 in the Outbreak of VOC Omicron BA.2 - Jilin City, Jilin Province, China, March 3-April 12, 2022. Fan X; Lu S; Bai L; Liu H; Fu J; Jin X; He Y; Lu J; Dong X China CDC Wkly; 2022 May; 4(18):377-380. PubMed ID: 35686205 [TBL] [Abstract][Full Text] [Related]
12. Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study. Lin Y; Wu P; Tsang TK; Wong JY; Lau EHY; Yang B; Leung GM; Cowling BJ Lancet Microbe; 2023 Sep; 4(9):e722-e731. PubMed ID: 37659420 [TBL] [Abstract][Full Text] [Related]
13. Using machine learning models to predict the duration of the recovery of COVID-19 patients hospitalized in Fangcang shelter hospital during the Omicron BA. 2.2 pandemic. Xu Y; Ye W; Song Q; Shen L; Liu Y; Guo Y; Liu G; Wu H; Wang X; Sun X; Bai L; Luo C; Liao T; Chen H; Song C; Huang C; Wu Y; Xu Z Front Med (Lausanne); 2022; 9():1001801. PubMed ID: 36405610 [TBL] [Abstract][Full Text] [Related]
14. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads. Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH medRxiv; 2022 Jan; ():. PubMed ID: 35118480 [TBL] [Abstract][Full Text] [Related]
15. [Characteristics and related factors of viral nucleic acid negative conversion in children infected with Omicron variant strain of SARS-CoV-2]. Yin R; Lu Q; Jiao JL; Lin K; Wang C; Yuan L; Ding Y; Dong N; Wang BJ; Niu YH; Fang YS; Liu W; Sun YF; Zou B; Zhang XE; Xiao P; Sun L; Du X; Zhu YY; Dong XY Zhonghua Er Ke Za Zhi; 2022 Dec; 60(12):1307-1311. PubMed ID: 36444435 [No Abstract] [Full Text] [Related]
16. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study. Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P; PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China. Yin Z; Fang Q; Wen T; Zheng C; Fu C; Wang S; Li J; Gong X Hum Vaccin Immunother; 2023 Dec; 19(1):2163813. PubMed ID: 36704960 [TBL] [Abstract][Full Text] [Related]
18. A Multi-Center Study Investigating Long COVID-19 in Healthcare Workers from North-Eastern Italy: Prevalence, Risk Factors and the Impact of Pre-Existing Humoral Immunity-ORCHESTRA Project. Cegolon L; Mauro M; Sansone D; Tassinari A; Gobba FM; Modenese A; Casolari L; Liviero F; Pavanello S; Scapellato ML; Taus F; Carta A; Spiteri G; Monaco MGL; Porru S; Larese Filon F Vaccines (Basel); 2023 Nov; 11(12):. PubMed ID: 38140174 [No Abstract] [Full Text] [Related]
19. Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022. Chen X; Yan X; Sun K; Zheng N; Sun R; Zhou J; Deng X; Zhuang T; Cai J; Zhang J; Ajelli M; Yu H medRxiv; 2022 Jul; ():. PubMed ID: 35898339 [TBL] [Abstract][Full Text] [Related]
20. Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case-control analysis. Lind ML; Robertson AJ; Silva J; Warner F; Coppi AC; Price N; Duckwall C; Sosensky P; Di Giuseppe EC; Borg R; Fofana MO; Ranzani OT; Dean NE; Andrews JR; Croda J; Iwasaki A; Cummings DAT; Ko AI; Hitchings MDT; Schulz WL PLoS Med; 2022 Dec; 19(12):e1004136. PubMed ID: 36454733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]